Minipill 0.2 mg (Desmopressin Acetate)

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only): Administer desmopressin acetate 0.1mg orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg; if the effect remains insufficient, the dose may be increased at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after dose titration. Initiation of treatment with this medicine is not recommended in patients aged 65 years and older. In elderly patients who require treatment, closely monitor serum sodium levels, etc. (Refer to 5. General precautions under Precautions for use.)

Child dose

Primary nocturnal enuresis (aged 5 years and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased to 0.4mg. Whether to continue treatment should be determined after 3 months of treatment, following a treatment-free period of at least 1 week.

This medication acts to regulate body fluid. When using this medication, extra caution should be taken, particularly for older individuals or those with certain diseases, as there is a risk of hyponatremia and coma due to excessive fluid, so it is advised to drink only enough water to prevent thirst. Individuals allergic to this medication, those with very high urine output due to habitual or psychological reasons, severe heart dysfunction, those taking diuretics, those with severely impaired kidney function, and individuals with certain genetic lactose intolerance should not use this medication. Those with high blood pressure or cardiovascular disease, patients with chronic kidney disease, pregnant women or women who may become pregnant, children, elderly individuals, and those at risk of electrolyte imbalance should exercise extra caution when using this medication. This medication can cause various side effects including allergic reactions, headaches, nausea, skin rashes, and hyponatremia, especially in the elderly or nocturia patients, where serious fluid overload and coma or seizures due to hyponatremia may occur, so caution is necessary. Fluid intake should be strictly limited one hour before and eight hours after administration, and in cases of poor kidney function, it should be restricted to a maximum of 0.5 liters for up to 12 hours after administration. This medication may interact with other drugs, so if you are currently taking other medications, be sure to consult with your healthcare provider. Pregnant or breastfeeding women should carefully consider the necessity and risks of using this medication, as it may affect the fetus or infant, and it is advisable to discontinue breastfeeding while using it. In case of overdose, symptoms such as headaches, nausea, seizures, and loss of consciousness may occur, and in such cases, immediate consultation with healthcare professionals and appropriate treatment should be sought.

unconsciousness

This medication may be sensitive to air or moisture, so it should be kept in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius. This will help preserve the effectiveness of the medication safely for a long time.

Appearance

White round tablet

Package unit

30 tablets/bottle